Showing 2061-2070 of 2314 results for "".
- Serum Institute to Produce COVID-19 Vaccines From AstraZeneca, Novavaxhttps://modernod.com/news/serum-institute-to-produce-covid-19-vaccines-from-astrazeneca-novavax/2478139/The Serum Institute of India (SII) said it will produce coronavirus vaccines from AstraZeneca and Novavax, making them available for procurement, if they gain marketing approval, at a ceiling price of $3 per dose. SII noted that it will use funding from Gavi, The Vaccine Alliance and the Bill &am
- Trump Signs Order to Boost Production of “Essential” Drugs in UShttps://modernod.com/news/trump-signs-order-to-boost-production-of-essential-drugs-in-us/2478135/President Donald Trump on Thursday signed an executive order requiring the federal government to purchase “essential” medicines from US companies. “As we’ve seen in this pandemic, the US must produce essential equipment supplies and pharmaceuticals for ourselves,” Tr
- Johnson & Johnson Forges $1-Billion Pact to Supply US with COVID-19 Vaccinehttps://modernod.com/news/johnson-johnson-forges-1-billion-pact-to-supply-us-with-covid-19-vaccine/2478133/Johnson & Johnson said it entered into an agreement with the US government for the large-scale domestic manufacturing and delivery of 100 million doses of its investigational SARS-CoV-2 vaccine Ad26.COV2.S for use in the country. Specifically, the US Biomedical Advanced Research and Developme
- Vision Expo Announces Virtual EYE2EYE Series Topics for Augusthttps://modernod.com/news/vision-expo-announces-virtual-eye2eye-series-topics-for-august/2478126/Vision Expo announced the upcoming Virtual EYE2EYE Series topics scheduled for August. August 5: SHE Did That! Dr. Danielle Richardson, Optometrist and Founder at Fierce Clarity, will explore the passionate pursuits of Black women in eyecare and their entrepreneurshi
- Cardio Risk Increases With Diabetic Retinopathy Progressionhttps://modernod.com/news/cardio-risk-increases-with-diabetic-retinopathy-progression/2478116/The risk for heart attack, stroke, and even death increases as the severity of diabetic retinopathy increases. Severe retinopathy is linked to a doubling of the risk for cerebrovascular accident or myocardial infarction, results from a new study show, as
- Can You Get COVID-19 Through Your Eyes? Possibly.https://modernod.com/news/can-you-get-covid-19-through-your-eyes-possibly/2478112/We know that the coronavirus can enter the body through the nose and mouth — hence the constant recommendations from doctors to wear face coverings and practice social distancing. But what abou
- Sanofi, GSK Gain $2.1 Billion From US Government for Development, Supply of COVID-19 Vaccinehttps://modernod.com/news/sanofi-gsk-gain-2-1-billion-from-us-government-for-development-supply-of-covid-19-vaccine/2478107/Sanofi and GlaxoSmithKline announced that the US government will provide more than $2.1 billion to support further development, manufacturing and delivery of initial doses of the companies’ adjuvanted vaccine against COVID-19. The vaccine candidate is based on Sanofi’s recombinant pro
- Pfizer, BioNTech Begin Phase 2/3 Coronavirus Vaccine Studyhttps://modernod.com/news/pfizer-biontech-pick-bnt162b2-to-advance-into-phase-2-3-coronavirus-vaccine-study/2478084/Pfizer and partner BioNTech said they have decided to advance the nucleoside-modified mRNA vaccine candidate BNT162b2 into phase 2/3 testing. The vaccine, to be trialed at the 30-mcg dose as part of a two-dose regimen, encodes for an optimized SARS-CoV-2 full-length spike glycoprotein, which the
- Pepcid As a Coronavirus Remedy? Trump’s $21-Million Gamble Fizzledhttps://modernod.com/news/pepcid-as-a-coronavirus-remedy-trumps-21-million-gamble-fizzled/2478070/As the coronavirus began its deadly march through the world, two well-respected American doctors identified a possible but seemingly unlikely remedy: Pepcid, the heartburn medication found on drugstore shelves everywhere, according to an Associated
- Pfizer, BioNTech’s mRNA-Based COVID-19 Vaccine Shows Promise in Second Studyhttps://modernod.com/news/pfizer-biontechs-mrna-based-covid-19-vaccine-shows-promise-in-second-study/2478049/Pfizer and BioNTech announced that the most advanced of four COVID-19 vaccine candidates from their BNT162 mRNA-based vaccine program demonstrated the ability to elicit high SARS-CoV-2 neutralising titers after the second dose in an ongoing phase 1/2 study in Germany. The results, which were publ
